MPM
CHE icon

Meritage Portfolio Management’s Chemed CHE Stock Holding History

Meritage Portfolio Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,237
Closed -$9.89M – 336
2024
Q2 		$9.89M Sell
18,237
-269
-1% -$154K 0.62% 33
2024
Q1 		$11.9M Sell
18,506
-815
-4% -$495K 0.76% 24
2023
Q4 		$11.3M Buy
19,321
+1,218
+7% +$682K 0.74% 25
2023
Q3 		$9.41M Sell
18,103
-136
-0.7% -$70.7K 0.69% 30
2023
Q2 		$9.88M Sell
18,239
-1,273
-7% -$696K 0.7% 28
2023
Q1 		$10.5M Sell
19,512
-568
-3% -$290K 0.79% 26
2022
Q4 		$10.3M Sell
20,080
-948
-5% -$461K 0.8% 24
2022
Q3 		$9.18M Sell
21,028
-271
-1% -$130K 0.76% 24
2022
Q2 		$10M Sell
21,299
-1,052
-5% -$513K 0.78% 25
2022
Q1 		$11.3M Buy
+22,351
New +$10.7M 0.7% 28

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Meritage Portfolio Management's CHE Position: Q3 2024 in Review

Meritage Portfolio Management sold out of Chemed (CHE) in Q3 2024, closing a stake of 18,237 shares — an estimated $9.89M sold.

Meritage Portfolio Management first reported a position in CHE in Q1 2022 and held it in 10 quarters. The position peaked at $11.9M in Q1 2024. 528 funds tracked by Wall St. Rank hold CHE as of Q3 2024.

  • Meritage Portfolio Management reported no remaining Chemed position as of Q3 2024 after selling out during the quarter.
  • Meritage Portfolio Management sold 18,237 Chemed shares in Q3 2024, an estimated $9.89M.
  • Meritage Portfolio Management first reported a position in Chemed in Q1 2022 and held it in 10 quarters.
  • Meritage Portfolio Management's Chemed position peaked at $11.9M in Q1 2024.
  • 528 funds tracked by Wall St. Rank held Chemed as of Q3 2024.

Based on Meritage Portfolio Management's 13F filing for Q3 2024, filed 4 Nov 2024.